Related Experiment Video
Updated: Jun 20, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration
Diana Romero1, Aleksandra Terzic, Barbara A Conley
1Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, ME 04074, USA.
Abstract:
Endoglin, a transmembrane glycoprotein that acts as a transforming growth factor-beta (TGF-beta) coreceptor, is downregulated in PC3-M metastatic prostate cancer cells. When restored, endoglin expression in PC3-M cells inhibits cell migration in vitro and attenuates the tumorigenicity of PC3-M cells in SCID mice, though the mechanism of endoglin regulation of migration in prostate cancer cells is not known. The current study indicates that endoglin is phosphorylated on cytosolic domain threonine residues by the TGF-beta type I receptors ALK2 and ALK5 in prostate cancer cells. Importantly, in the presence of constitutively active ALK2, endoglin did not inhibit cell migration, suggesting that endoglin phosphorylation regulated PC3-M cell migration. Therefore, our results suggest that endoglin phosphorylation is a mechanism with relevant functional consequences in prostate cancer cells. These data demonstrate for the first time that TGF-beta receptor-mediated phosphorylation of endoglin is a Smad-independent mechanism involved in the regulation of prostate cancer cell migration.
Insights
Endoglin phosphorylation by TGF-beta receptors regulates prostate cancer cell migration. This Smad-independent mechanism is crucial for controlling metastatic prostate cancer cell movement.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Endoglin, a TGF-beta coreceptor, is downregulated in metastatic prostate cancer cells (PC3-M).
- Restored endoglin expression inhibits PC3-M cell migration and tumorigenicity, but the mechanism is unknown.
Purpose of the Study:
- To elucidate the mechanism by which endoglin regulates prostate cancer cell migration.
- To investigate the role of endoglin phosphorylation in this process.
Main Methods:
- Investigated endoglin phosphorylation in prostate cancer cells.
- Utilized TGF-beta type I receptors ALK2 and ALK5 in phosphorylation studies.
- Assessed the effect of constitutively active ALK2 on endoglin's ability to inhibit cell migration.
Main Results:
- Endoglin is phosphorylated on cytosolic threonine residues by ALK2 and ALK5 in prostate cancer cells.
- Constitutively active ALK2 abrogated endoglin's inhibitory effect on PC3-M cell migration.
- Endoglin phosphorylation directly regulates prostate cancer cell migration.
Conclusions:
- Endoglin phosphorylation by TGF-beta receptors is a key regulator of prostate cancer cell migration.
- This phosphorylation acts via a Smad-independent pathway, offering novel therapeutic targets.
Related Concept Videos
Cancer Cell Migration through Invadopodia
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply
Cell Migration
Cell Migration

